Characteristics and prognosis of young breast cancer patients treated in a public comprehensive cancer centre in Brazil: A retrospective cohort study.

[1]  S. Loi,et al.  Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer. , 2022, The New England journal of medicine.

[2]  L. Testa,et al.  Breast cancer trends in women younger than 40 years in Brazil. , 2022, Cancer epidemiology.

[3]  E. Winer,et al.  Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer. , 2022, The New England journal of medicine.

[4]  L. Rocha-Zavaleta,et al.  Perinatal outcomes in young women with breast cancer and pregnancy. , 2022, Gaceta Médica de México.

[5]  H. Abdel-Razeq,et al.  Differences in clinicopathological characteristics, treatment, and survival outcomes between older and younger breast cancer patients , 2021, Scientific Reports.

[6]  V. Sopik.  International variation in breast cancer incidence and mortality in young women , 2020, Breast Cancer Research and Treatment.

[7]  M. Kuroda,et al.  Differences in clinicopathologic features and subtype distribution of invasive breast cancer between elderly and non-elderly women , 2020, Fujita medical journal.

[8]  Sung-Bae Kim,et al.  Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study. , 2020, The Lancet. Oncology.

[9]  E. Baracat,et al.  Ethical issues surrounding breast cancer screening in Brazil , 2019, Clinics.

[10]  C. Barrios,et al.  Advanced Stage at Diagnosis and Worse Clinicopathologic Features in Young Women with Breast Cancer in Brazil: A Subanalysis of the AMAZONA III Study (GBECAM 0115) , 2019, Journal of global oncology.

[11]  J. Boughey,et al.  Adolescents and Young Adults with Breast Cancer have More Aggressive Disease and Treatment Than Patients in Their Forties , 2019, Annals of Surgical Oncology.

[12]  C. Barrios,et al.  Characteristics and prognosis of stage I-III breast cancer subtypes in Brazil: The AMAZONA retrospective cohort study. , 2019, Breast.

[13]  A. Stein,et al.  Guidelines for early detection of breast cancer in Brazil . III – Challenges for implementation , 2018 .

[14]  Lunpo Wu,et al.  How Young Is Too Young in Breast Cancer?—Young Breast Cancer Is Not a Unique Biological Subtype , 2017, Clinical breast cancer.

[15]  A. Partridge,et al.  Prognosis of pregnancy-associated breast cancer , 2017, Breast Cancer Research and Treatment.

[16]  C. Compton,et al.  The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging , 2017, CA: a cancer journal for clinicians.

[17]  F. Cardoso,et al.  Breast Cancer Under Age 40: a Different Approach , 2015, Current Treatment Options in Oncology.

[18]  D. Altman,et al.  Prospective observational study of breast cancer treatment outcomes for UK women aged 18-40 years at diagnosis: the POSH study. , 2013, Journal of the National Cancer Institute.

[19]  P. Fasching,et al.  Ki67 Measured after Neoadjuvant Chemotherapy for Primary Breast Cancer , 2013, Clinical Cancer Research.

[20]  A. Kurian,et al.  Occurrence of breast cancer subtypes in adolescent and young adult women , 2012, Breast Cancer Research.

[21]  C. Sotiriou,et al.  Elucidating Prognosis and Biology of Breast Cancer Arising in Young Women Using Gene Expression Profiling , 2012, Clinical Cancer Research.

[22]  Jack Cuzick,et al.  Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group. , 2011, Journal of the National Cancer Institute.

[23]  M. Dowsett,et al.  American society of clinical oncology/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. , 2010, Journal of oncology practice.

[24]  M. Seoud,et al.  Trends in epidemiology and management of breast cancer in developing Arab countries: a literature and registry analysis. , 2007, International journal of surgery.

[25]  A. Luini,et al.  Very young women (<35 years) with operable breast cancer: features of disease at presentation. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[26]  S. Rodriguez-Cuevas,et al.  Breast carcinoma presents a decade earlier in Mexican women than in women in the United States or European countries , 2001, Cancer.

[27]  L. Ouldamer,et al.  [Pregnancy after breast cancer: A literature review]. , 2019, Presse medicale.